Asandeutertinib
Asandeutertinib (Osimertinib-d3; AZD-9291-d3) is a epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, with antineoplastic effect[1].
Product Specifications
CAS Number
1638281-46-5
Product Name Alternative
Asandeutertinibum; Osimertinib-d3; AZD-9291-d3
UNSPSC
12352005
Target
EGFR
Type
Isotope-Labeled Compounds
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Purity
99.75
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
COC(C=C(C(NC(C=C)=O)=C1)N(C)CCN(C)C)=C1NC2=NC=CC(C(C3=CC=CC=C34)=CN4C([2H])([2H])[2H])=N2
Molecular Formula
C28H30D3N7O2
Molecular Weight
502.63
References & Citations
[1]Asandeutertinib (asandeutertinibum; Osimertinib-d3; AZD-9291-d3) . WHO Drug Information, Vol. 37, No. 4, 2023.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B642500-25MG 25 mg
N2-t-Boc-N6-(biotinamido-6-N-caproylamido)lysine
Sign In for Pricing
View Details 